ArticleJournal of endocrinological investigation2026

Biglycan knockdown improves Graves' orbitopathy (GO)-like features via inhibiting NF-kB and ERK signaling.

Changci Chenzhao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.